Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution
Phase 1
Completed
- Conditions
- Catheter-Associated InfectionsCatheter-Related Infections
- Interventions
- Drug: Nitroglycerin-citrate-ethanol (NiCE)
- First Posted Date
- 2015-10-16
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Novel Anti-Infective Technologies, LLC
- Target Recruit Count
- 60
- Registration Number
- NCT02577718
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
News
No news found